Cargando…

Athero-protective actions of two oral antidiabetic drugs: Suppression of inflammation and oxidative stress

Detalles Bibliográficos
Autor principal:	Chen, Kan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2012
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3271678/ https://www.ncbi.nlm.nih.gov/pubmed/22346137

Ejemplares similares

Hydrogen sulfide mediates athero-protection against oxidative stress via S-sulfhydration
por: Cheung, Sau Ha, et al.
Publicado: (2018)

Acute coronary disease Athero-Inflammation: Therapeutic approach
por: Altman, Raul
Publicado: (2003)

The Alcohol–High-Density Lipoprotein Athero-Protective Axis
por: Rosales, Corina, et al.
Publicado: (2020)

Risk factors in coronary atherosclerosis athero-inflammation: the meeting point
por: Altman, Raul
Publicado: (2003)

Impact of oral antidiabetic agents on bone metabolism
por: Paul, Thomas V., et al.
Publicado: (2015)

Oral Cholecalciferol Supplementation in Sahara Black People with Chronic Kidney Disease Modulates Cytokine Storm, Oxidative Stress Damage and Athero-Thromboembolic Risk
por: Zoubiri, Houda, et al.
Publicado: (2022)

Cell-specific and athero-protective roles for RIPK3 in a murine model of atherosclerosis
por: Colijn, Sarah, et al.
Publicado: (2020)

Colchicine in Athero-Thrombosis: Molecular Mechanisms and Clinical Evidence
por: Cimmino, Giovanni, et al.
Publicado: (2023)

CD8(+) T Cells Mediate the Athero-Protective Effect of Immunization with an ApoB-100 Peptide
por: Chyu, Kuang-Yuh, et al.
Publicado: (2012)

Schistosoma mansoni Infection-Induced Transcriptional Changes in Hepatic Macrophage Metabolism Correlate With an Athero-Protective Phenotype
por: Cortes-Selva, Diana, et al.
Publicado: (2018)

Pharmacogenetics of Oral Antidiabetic Drugs
por: Becker, Matthijs L., et al.
Publicado: (2013)

Selective Insulin Receptor Modulators (SIRM): A New Class of Antidiabetes Drugs?
por: Vigneri, Riccardo, et al.
Publicado: (2012)

Sodium–glucose cotransporter 2 inhibitors: A drug with antidiabetic and cardioprotective properties
por: Li, Hung‐Yuan
Publicado: (2020)

Using AHRQ’s Evidence-Based Reports to Improve Managed Care Pharmacy Practice: Oral Antidiabetic Agents
por: Yeung, Kai
Publicado: (2011)

The Effect of All Extremity High Intensity Interval Training on Athero-Protective Factors and Endothelial Function in Overweight and Obese Women
por: Hovsepian, Volga, et al.
Publicado: (2021)

New Antidiabetes Agent Targeting Both Mitochondrial Uncoupling and Pyruvate Catabolism: Two Birds With One Stone
por: Rui, Liangyou
Publicado: (2019)

Antiphospholipid Antibodies and Heart Failure with Preserved Ejection Fraction. The Multicenter ATHERO-APS Study
por: Pastori, Daniele, et al.
Publicado: (2021)

Crosstalk between gut microbiota and antidiabetic drug action
por: Kyriachenko, Yevheniia, et al.
Publicado: (2019)

Drug Transport Mechanism of Oral Antidiabetic Nanomedicines
por: Gundogdu, Evren, et al.
Publicado: (2014)

Transporter-Mediated Drug–Drug Interactions with Oral Antidiabetic Drugs
por: Klatt, Sabine, et al.
Publicado: (2011)

An Overview of the Cardioprotective Effects of Novel Antidiabetic Classes: Focus on Inflammation, Oxidative Stress, and Fibrosis
por: Balogh, Dora Bianka, et al.
Publicado: (2023)

Oxidative/Nitrosative Stress and Protein Damages in Aqueous Humor of Hyperglycemic Rabbits: Effects of Two Oral Antidiabetics, Pioglitazone and Repaglinide
por: Gumieniczek, Anna, et al.
Publicado: (2012)

Risk Factors of Coronary Artery Disease in Secondary Prevention—Results from the AtheroGene—Study
por: Zengin, Elvin, et al.
Publicado: (2015)

Arterial endothelial methylome: differential DNA methylation in athero-susceptible disturbed flow regions in vivo
por: Jiang, Yi-Zhou, et al.
Publicado: (2015)

Antidiabetic Drugs in Alzheimer's Disease: Mechanisms of Action and Future Perspectives
por: Femminella, Grazia Daniela, et al.
Publicado: (2017)

New therapeutic strategy for Alzheimer's disease using antidiabetes agents
por: Yokono, Koichi
Publicado: (2013)

How many oral antidiabetic drugs before insulin?
por: Kelwade, Jayant, et al.
Publicado: (2017)

Circulating Lipopolysaccharides and Impaired Antioxidant Status in Patients With Atrial Fibrillation. Data From the ATHERO-AF Study
por: Menichelli, Danilo, et al.
Publicado: (2021)

Mechano-sensitive TET1s inhibits endothelial athero-susceptible phenotype through regulating YAP phosphorylation
por: Huang, Lu, et al.
Publicado: (2023)

Cancer and diabetes: the interlinking metabolic pathways and repurposing actions of antidiabetic drugs
por: Olatunde, Ahmed, et al.
Publicado: (2021)

Is the Oral Microbiome Important in HIV-Associated Inflammation?
por: Fulcher, Jennifer A.
Publicado: (2020)

Complexity of NAC Action as an Antidiabetic Agent: Opposing Effects of Oxidative and Reductive Stress on Insulin Secretion and Insulin Signaling
por: Argaev-Frenkel, Lital, et al.
Publicado: (2022)

Geraniol Suppresses Oxidative Stress, Inflammation, and Interstitial Collagenase to Protect against Inflammatory Arthritis
por: Malik, Muhammad Nasir Hayat, et al.
Publicado: (2023)

Comparative effectiveness of incident oral antidiabetic drugs on kidney function
por: Hung, Adriana M, et al.
Publicado: (2012)

Aging-Related Decline of Autophagy in Patients with Atrial Fibrillation—A Post Hoc Analysis of the ATHERO-AF Study
por: Versaci, Francesco, et al.
Publicado: (2022)

Anticholinergic drugs and risk of dementia: Time for action?
por: Bell, Brian, et al.
Publicado: (2021)

Taking action on developmental toxicity: Scientists’ duties to protect children
por: Shrader-Frechette, Kristin
Publicado: (2012)

Antidiabetic Drugs in NAFLD: The Accomplishment of Two Goals at Once?
por: Tacelli, Matteo, et al.
Publicado: (2018)

Apolipoprotein M and Sphingosine-1-Phosphate: A Potentially Antidiabetic Tandem Carried by HDL
por: Yalcinkaya, Mustafa, et al.
Publicado: (2020)

Antidiabetic Effect and Mode of Action of Cytopiloyne
por: Chang, Cicero Lee-Tian, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_aj5lob5b04uhjiqrbgkahr2hvh